|
|
Researchers have identified a protein released by dying brain tumor cells that provides an effective way to gauge the effectiveness of a novel gene therapy treatment for brain cancer. The finding paves the way for a Phase 1 clinical trial expected to begin in late 2009. The two-pronged gene therapy was devised by scientists at the Cedars-Sinai Board of Governors Gene Therapeutics Research Institute. It uses a harmless, genetically engineered virus to deliver a combination of proteins and a drug to kill tumor cells, which triggers an ongoing immune response, thus preventing the development of recurrent malignant brain tumor cells. The Cedars-Sinai team, led by Pedro R. Lowenstein, M.D., Ph.D., director of the Board of Governors Gene Therapeutics Research Institute, and Maria G. Castro, Ph.D., co-director of the Institute,... [read full story]
I first saw Shams Kareem rocking back and forth on the floor of her home in Baghdad last February. At the sound of a visitor, she stood up and fumbled along the wall with her arms stretched out. “Carry, carry,” she called. Then...
Cheryl Cole, the singer with the luscious locks, is facing a bad hair day. The Advertising Standards Authority (ASA) said it had rejected 13 complaints that the ads were misleading because the disclaimer about Cole’s hair...
Isabel Oakeshott and Steven Swinford JACK STRAW is preparing to draw up proposals for wholesale reform of England’s libel laws, after a long-running Sunday Times campaign. The huge payouts awarded to individuals who...
Eco expert: Fred Pearce is an environmental consultant to New Scientist magazine Last week it was revealed that 54 oil tankers are anchored off the coast of Britain, refusing to unload their fuel until prices have risen. For 31...
